Tolerogenic dendritic cells inhibit inflammatory responses against self-antigens, offering a therapeutic strategy for autoimmune diseases. This Review describes the nanotechnology-based approaches available to target dendritic cells and induce tolerogenic properties, highlighting applications in organ transplantation, multiple sclerosis and diabetes mellitus.
- Anna Cifuentes-Rius
- Anal Desai
- Nicolas H. Voelcker